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        Atherosclerosis is a chronic infl  ammatory disease 
and one of the major causes of death worldwide 
(  1  ). The traditional pathophysiological paradigm 
of atherosclerosis includes proinfl  ammatory me-
diators such as IL-6 family cytokines ( 2, 3 ), which 
stimulate an acute phase response (APR) via their 
hepatocyte gp130 receptor component. Acute 
phase proteins, e.g., C-reactive protein, serum 
amyloid A (SAA), and most likely others, are 
strong and consistent infl  ammatory markers that 
are associated with cardiovascular events, i.e., 
myocardial infarction (MI), stroke, peripheral ar-
tery disease, and sudden cardiac death in healthy 
individuals, as well as in patients with acute coro-
nary syndromes (  4, 5  ). The IL-6 cytokine family 
includes IL-6, IL-11, leukemia inhibitory factor 
(LIF), oncostatin M (OSM), ciliary neurotrophic 
factor (CNTF), and cardiotrophin-1 (CT-1), 
which share the signal transducer gp130 in 
their receptors. After receptor  –  ligand binding, 
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  Liver-derived acute phase proteins (APPs) emerged as powerful predictors of cardiovascular 
disease and cardiovascular events, but their functional role in atherosclerosis remains 
enigmatic. We report that the gp130 receptor, which is a key component of the infl  amma-
tory signaling pathway within hepatocytes, infl  uences the risk of atherosclerosis in a 
hepatocyte-specifi  c gp130 knockout. Mice on an atherosclerosis-prone genetic background 
exhibit less aortic atherosclerosis (P  0.05) with decreased plaque macrophages (P  0.01). 
Translating these fi  ndings into humans, we show that genetic variation within the human 
gp130 homologue, interleukin 6 signal transducer (IL6ST), is signifi  cantly associated with 
coronary artery disease (CAD; P  0.05). We further show a signifi  cant association of 
atherosclerotic disease at the ostium of the coronary arteries (P  0.005) as a clinically 
important and heritable subphenotype in a large sample of families with myocardial infarc-
tion (MI) and a second independent population–based cohort. Our results reveal a central 
role of a hepatocyte-specifi  c, gp130-dependent acute phase reaction for plaque develop-
ment in a murine model of atherosclerosis, and further implicate IL6ST as a genetic 
susceptibility factor for CAD and MI in humans. Thus, the acute phase reaction should be 
considered an important target for future drug development in the management of CAD. 1936 GP130 SIGNALING IN ATHEROSCLEROSIS | Luchtefeld et al.
domain (  12  ). For this animal model, it was recently reported 
that a 90% deletion of exon 16 could be observed in the 
liver of adult mice (  13  ). In these mice, the induction of 
an APR is strongly impaired (  13  ). To defi  ne the role of the 
dimerization of gp130 occurs, which activates intracellular sig-
naling cascades, such as the JAK  –  signal transducer and activator 
of transcription (STAT) pathway and the SH2-containing tyro-
sine phosphatase 2 (SHP2)  –  RAS  –  mitogen-activated protein 
kinase (MAPK) pathway, via tyrosine phosphorylation. Acti-
vated JAKs phosphorylate tyrosine residues in the cytoplasmatic 
tail of gp130, providing docking sites for the SH2 domain of 
STAT1, STAT3, and SHP2, which are subsequently phos-
phorylated by JAKs. SHP2 is an adaptor that links tyrosine-
phosphorylated receptors and the activation of the RAS  –  MAP 
kinase signaling pathway (  6, 7  ). Moreover, Schaper et al. dem-
onstrated that activation of SHP2 via gp130 requires tyrosine 
kinase Jak1 and limits acute-phase protein expression (  8  ). 
  Upon gp130 activation, various APPs are produced within 
hepatocytes; in humans, mainly CRP and SAA, fi  brinogen, 
haptoglobin, and angiotensinogen are produced. In mice, SAA 
represents the predominant APP, whereas CRP is a minor 
APP, potentially caused by the limited responsiveness of the 
gene to infl  ammatory cytokine signals (  9  ). The transient APR 
is the immediate set of infl  ammatory reactions that is thought 
to serve as a fi  rst-line response of unspecifi  c immune defence 
to counteract tissue injury and bacterial or fungal infections. 
CRP and SAA are nonspecifi  c, but sensitive, markers of 
infection and tissue infl  ammation; they also possess intrinsic 
biological properties, such as activating the complement cascade, 
mediating phagocytosis, and regulating the infl  ammatory 
response (  10  ). Interestingly, patients with a chronically ac-
tivated infl  ammatory response, e.g., those with rheumatoid 
arthritis or lupus erythematosus, have an increased risk of 
atherosclerotic cardiovascular events, suggesting that the per-
sistence of the APR over a prolonged period of time may 
have detrimental cardiovascular consequences. We further 
investigate the role of gp130 in regard to functional mecha-
nisms related to the development of CAD. We demonstrate 
that a hepatocyte-specifi  c knockout mouse for gp130 on an 
atherosclerosis-prone background exhibits less aortic athero-
sclerosis, which is concomitant with a decrease of macro-
phages in the lesions. Translating the functional evidence 
from the animal model to humans, genetic association studies 
can evaluate whether a gene and genetic variation in a candi-
date gene contributes signifi  cantly to the disease process. 
Genetic association analysis in two independent populations 
show consistent evidence for association, supporting the notion 
that gp130 infl  uences the risk of atherosclerosis in humans. 
The combined evidence from both animals and humans pro-
vides a functional mechanism of action in the animal model 
and suggests that gp130 plays an important role in the athero-
sclerotic disease process in humans. 
    RESULTS   
  Hepatocyte-specifi  c gp130 knockout 
infl  uences atherosclerosis 
  Transgenic mice expressing the Cre recombinase (Cre) under 
the control of the hepatocyte-specifi  c albumin promoter (  11  ) 
were crossed with animals carrying the gp130 gene with loxP 
sites fl  anking exon 16, coding for the gp130 transmembrane 
  Figure 1.     Analysis of murine hepatocyte-specifi  c gp130 knockout. 
(A) Confi  rmation of gp130 deletion specifi  cally in the liver by PCR. The 
forward primer anneals in exon 15 and the reverse primer anneals in exon 17. 
Cre-mediated excision of the lox-fl  anked exon 16 leads to an amplifi  ed 
PCR-fragment of 1,000 bp. Genotyping of all samples for apoE 
defi  ciency was performed as a positive control for DNA amplifi  cation. 
(B) Isolated hepatocytes of all three genotypes after stimulation with 
50 ng/ml of the IL-6 cytokine LIF. The Western blot of cellular protein shows 
strong STAT3 tyrosine phosphorylation in the case of the controls with 
intact gp130, but only a weak signal in the case of gp130− hepatocytes. 
STAT3 served as loading control. Intensities of phosphorylated STAT3 and 
total STAT3 were quantifi  ed, and fold induction was calculated relative to 
unstimulated controls (mean  the SEM; n  4; *, P  0.05 vs. gp 130+; 
#, P  0.05 vs. gpfl  ox). (C) SAA concentration in the supernatant of LIF-
stimulated hepatocytes. Under control conditions, 0.25  0.1 μg/ml SAA 
were measured in the supernatant of LIF-stimulated gp130−-derived 
hepatocytes in comparison to 1.4  0.04 μg/ml SAA, which is released 
from gp130fl  ox-derived hepatocytes and 1.3  0.1 μg/ml SAA, which is 
released from gp130+-derived hepatocytes. SAA release peaks after 1 h of 
LIF stimulation (0.64  0.24 μg/ml from gp130−-derived hepatocytes, 
7.3  0.97 μg/ml from gp130fl  ox-derived hepatocytes, and 7.4  0.1 μg/ml 
SAA from gp130+-derived hepatocytes; mean the SD;   n    5; 
  * ,  P   0.05 vs. gp130fl  ox;   # ,  P   0.05 vs. gp130+).     JEM VOL. 204, August 6, 2007 
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gp130 (22.6  3.9%) versus gp130fl  ox (33.8  2.2%) animals 
(  Fig. 2 E  ). Corresponding to this fi  nding, we observed a re-
duced mRNA expression of macrophage chemoattractant 
protein-1 (CCL2, formerly known as MCP-1) in aortic tissue 
of gp130 mice (  Fig. 2 F  ) and signifi  cantly less circulating 
CCL2 protein in the plasma of gp130 mice (  Fig. 2 G  ). 
  Because CCL2 expression is required for monocyte/
macrophage recruitment into the vessel wall, we deter-
mined CCL2 in isolated mouse aortic smooth muscle cells 
(MASMCs) after SAA stimulation. A dose  –  response curve 
for SAA revealed a signifi  cant release of CCL2 at a SAA con-
centration of 25 g/ml, which further increased at a SAA 
concentration of 50 g/ml (  Fig. 3 A  ).   CCL2 mRNA expres-
sion was already increased at 1 h, followed by a marked re-
lease of the protein into the supernatant after 3 h (  Fig. 3, B 
and C  ). Subsequently, we tested supernatants from stimulated 
hepatocytes isolated from our diff  erent mouse genotypes 
(gp130  –   and gp130fl  ox) for their ability to induce CCL2 re-
lease from MASMCs isolated from wild-type mice (C57BL/6). 
CCL2 release from MASMCs was enhanced when stimu-
lated with supernatant from gp130fl  ox hepatocytes, and was 
signifi  cantly reduced when stimulated with supernatant from 
gp130  –   hepatocytes (  Fig. 3 D  ). To investigate whether SAA 
is the APP responsible for macrophage migration, we stimu-
lated macrophages with the supernatant from gp130fl  ox he-
patocytes pretreated with a SAA antibody and compared the 
migratory effi   ciency with macrophages stimulated with the 
supernatant from gp130fl  ox hepatocytes pretreated with an 
unspecifi   c IgG. We observed a reduced migration when 
stimulated with the SAA-pretreated supernatant (54.5  10.5% 
migration with SAA-AB  –  treated supernatant, compared with 
100  16.6% migration with IgG-treated supernatant; *, P  
0.05 vs. IgG-pretreated supernatant), pointing to an SAA-
dependent migration of macrophages in murine atheroscle-
rosis. To identify further proteins that are potentially involved 
in macrophage migration, a mouse cytokine protein array from 
SAA-stimulated (25 g/ml for 3 h) smooth muscle cells (SMCs) 
was performed. Array analysis is summarized in Fig. S1 (available 
at http://www.jem.org/cgi/content/full/jem.20070120/DC1). 
Chemokines such as keratinocyte-derived chemokine (4.4  
0.8-fold), macrophage infl  ammatory protein 2 (1.5  0.1-fold), 
and CCL2 (2.1  0.2-fold) are signifi  cantly increased upon 
SAA stimulation, whereas proinfl  ammatory cytokines, such as 
IL-6 (1.0  0.2-fold) and IL-1 (1.2  0.1-fold), remained 
unchanged compared with the unstimulated control. CCL2 
liver-derived APR in atherosclerosis, these genetic variations 
were transferred onto a background susceptible for this disease, 
apoE/ mice. For identifi  cation of the diff  erent genotypes, 
the following abbreviations are used: gp130  –   for cre  tg  ;gp130    fl  ox/fl  ox  ;
apoE/, gp130fl  ox for gp130   fl  ox/fl  ox  ;apoE/ (control), and 
gp130+ for gp130  +/+  ;apoE/ (control). Phenotypically, the 
mice showed no signifi  cant diff  erences. Moreover, pilot studies 
without cholesterol feeding revealed neither increased mor-
tality nor increased number of infectious diseases in all three 
mice strains. To verify that the genetic modifi  cations were 
successful, as expected, the specifi  city of the Cre-mediated 
deletion, as well as the absence of the APR, was confi  rmed 
(  Fig. 1  ).   Using a PCR reaction specifi  c for the deletion, we 
demonstrate gene inactivation exclusively in liver, but not in 
heart, aorta, or spleen (  Fig. 1 A  ). Using isolated hepatocytes, 
we confi  rmed that after stimulation with LIF, which is a 
member of the IL-6 family, induction of STAT3 phosphoryl-
ation (  Fig. 1 B  ) and the APR as determined by SAA production 
(  Fig. 1 C  ) are greatly reduced in gp130  –   mice, but strongly 
increased in the controls. 
  Next, we analyzed the impact of hepatocyte-specifi  c 
gp130 deletion on atherosclerosis in 10-wk-old male mice 
after feeding with a high-fat, Western-type diet for 8 and 
12 wk. Mice were assessed for aortic plaque formation by en 
face preparation after oil red O staining. Additionally, total 
lesion size was analyzed in aortic root sections after oil red O 
staining (  Fig. 2 A,   right).   The quantifi  cation revealed that the 
atherosclerotic plaque area was reduced by 50% (P  0.05) 
after 8 wk of feeding and 50% (P  0.03) after 12 wk of feed-
ing in aortas and aortic roots of gp130  –   mice (oil red O  –  posi-
tive area: 2.5  1.9% after 8 wk and 6.2  2.3% after 12 wk, 
compared with gp130fl  ox [6.2  0.5% after 8 wk and 13.2  
4.8% after 12 wk] and gp130	 mice [6.4  2.8% after 8 wk 
and 13.4  2.7% after 12 wk]; total lesion area: 0.05  0.06 
after 8 wk and 0.34  0.11 after 12 wk compared with 
  gp130fl  ox [0.46  0.17 after 8 wk and 0.58  0.09 after 12 wk] 
and gp130	 [0.47  0.14 after 8 wk and 0.51  0.09 after 
12 wk];   Fig. 2 B  ). Because the in vitro and in vivo experi-
ments revealed no phenotypic diff  erences between the gp-
130fl  ox and gp130	 control groups, further analyses were 
performed on gp130 animals using gp130fl  ox as control. 
  Markers of infl  ammation in gp130 knockout 
  Next, we investigated whether feeding with a high-fat, Western-
type diet aff  ects plasma SAA levels in these mice. We observed 
signifi  cantly lower SAA levels in the plasma of gp130 mice 
compared with gp130fl  ox (  Fig. 2 C  ), whereas plasma total 
cholesterol (TC) levels were not diff  erent between the experi-
mental groups (  Table I  ). 
  Because macrophage recruitment to the vessel wall and 
foam cell formation are hallmarks of atherosclerotic plaque 
development, we delineated the role of an APR on macro-
phage recruitment into aortic plaques by immunohistochemistry 
using monocytes/macrophages staining (MOMA-2 antisera; 
  Fig. 2 D  ). The quantitative analysis revealed a signifi  cant re-
duction of macrophage-positive plaque area (P  0.01) in 
    Table I.    Plasma lipids of Western diet  –  treated mice 
milligrams/deciliter gp130  – gp130fl  ox
TC 828  98 705  70
triglycerides 147  36 146  31
VLDL cholesterol 437  68 385  51
LDL cholesterol 299  31 264  20
HDL cholesterol 56  4 56  3
Plasma TC levels after 12 wk of Western diet are not signifi  cantly different between 
the experimental groups (mean  SEM;   n    7).1938 GP130 SIGNALING IN ATHEROSCLEROSIS | Luchtefeld et al.
  Figure 2.     Analysis of atherosclerosis. Male mice were fed a Western-type diet for 8 and 12 wk. (A) representative en face preparation of aortas (left) 
and aortic roots (right) stained with oil red O. Red color shows lipid-laden areas representing atherosclerotic lesion coverage. Bar: (left) 1 cm; (right) 500 m. 
(B) Quantifi  cation of oil red O stained areas as a percentage of whole aortic area (left) or as a total lesion area in the aortic root (right; 8-wk feeding: mean  
the SD;   n    4; *, P  0.05 vs. gp130fl  ox and gp130	; 12-wk feeding: mean  the SD;   n    4  –  7;   # ,  P   0.05 vs. gp130fl  ox and gp130+). (C) SAA concentra-
tion in plasma is signifi  cantly reduced in gp130  –   mice showing the lack of induction of this major hepatocyte-derived acute phase protein in response to the 
Western diet (mean  the SD;   n    7; *, P  0.01 vs. gp130fl  ox). (D) Representative immunohistochemical staining for monocytes/macrophages (MOMA-2) 
demonstrates less accumulation of macrophages in the plaque areas of gp130  –   mice. Bar, 50 m. (E) Quantifi  cation of MOMA-2 positively stained area as a 
percentage of the plaque area (mean  the SEM;   n    7 animals/group with 23  –  43 plaques; *, P  0.01 vs. gp130fl  ox). The whole aorta was analyzed by sys-
tematic cross sectioning. (F) Semiquantitative RT-PCR of aortas after Western diet reveals reduced gene expression of CCL2 in gp130  –   mice, the gene respon-
sible for monocyte attraction, whereas the expression of the corresponding receptor CCR2 is not altered (mean the SD;   n    7; *, P  0.05 vs. gp130fl  ox). 
(G) CCL2 concentration in the plasma after Western diet is signifi  cantly reduced in gp130  –   mice (mean  the SEM;   n    7  –  9; *, P  0.03 vs. gp130fl  ox).    JEM VOL. 204, August 6, 2007 
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  Human genetic association of polymorphisms 
in the IL6ST/gp130 gene 
  We next examined polymorphisms in the human gp130 
homologue, the IL6ST gene, in a large study sample of 513 
families of Western European descent with MI. An indepth 
description of the patient ascertainment strategy and the clin-
ical characteristics of the study population have been previ-
ously described (  15  ). We tested a total of 11 single-nucleotide 
polymorphisms (SNPs) located in the IL6ST gene, capturing 
9 SNPs located within a single 31-kb haplotype block and 
2 fl  anking SNPs (  Fig. 5  , Haploview LD output), and evaluated 
the association with coronary artery disease (CAD) and clini-
cal subphenotypes using the QTDT genetic analysis soft-
ware packages (  15  ).   Single-point analysis identifi  ed one SNP 
(rs10940495) that was signifi  cantly associated with CAD be-
fore (P  0.05) and after adjustment (P  0.01) for age, sex, 
smoking, diabetes, CAD/MI, TC/high-density lipoprotein 
(HDL) ratio, lipid medication, and SNPs in the CRP gene 
that were previously associated with CRP levels (  16  ). Two 
additional SNPs (rs3729960 and rs1900173) located in the 
is a member of the CC chemokine subfamily and predom-
inantly attracts monocytes, whereas CXC family members, 
such as keratinocyte-derived chemokine and macrophage 
infl  ammatory protein 2, particularly induce the migration 
of neutrophils. 
  Because deletion of CCR2 in apoE/ mice reduces 
atherosclerotic plaque development by decreasing macro-
phage recruitment to the atherosclerotic plaque (  14  ), we 
next tested in a mouse macrophage cell line whether the 
decreased synthesis and release of APP in gp130 mice pre-
vents cell migration.   Fig. 4 A   shows a strong increase in 
CCR2 transcripts in macrophages as early as 1 h after stimu-
lation with SAA, whereas   Fig. 4 B   demonstrates enhanced 
migration of macrophages toward CCL2 after preincuba-
tion with SAA as a functional consequence of increased 
CCR2 expression.   According to the cell culture experi-
ments with MASMCs, macrophages were also stimulated 
with supernatant from isolated hepatocytes. Migration to-
ward CCL2 (  Fig. 4 C  ) was markedly enhanced when chal-
lenged with supernatant derived from gp130fl  ox hepatocytes 
compared with supernatant from gp130 hepatocytes of 
atherosclerotic plaques. 
  Figure 3.     Stimulation experiments with mouse aortic smooth muscle 
cells (MASMC) isolated from wild-type mice (C57BL/6). (A) The cells 
were stimulated with SAA in different concentrations (12.5  –  50 g/ml 
in DME). Measurement of CCL2 release in the supernatant was per-
formed and shows a signifi  cant dose-dependent release of CCL2 at a 
SAA concentration of 25 g/ml, which further increases at a concen-
tration of 50 g/ml. To exclude LPS-dependent effects derived from 
recombinant produced SAA, a polymyxin B assay was performed (Fig. S2). 
(B) Semiquantitative RT-PCR shows the time-dependent induction of 
CCL2 mRNA (mean  the SEM;   n    5; *, P  0.02 vs. 0 h). (C) Measure-
ment of the supernatant of the same cells as in A shows the release of 
CCL2 (mean  the SD;   n    5; *, P  0.01 vs. 0 h). (D) Measurement of 
CCL2 concentration in the supernatants of MASMCs, demonstrating an 
increased release of CCL2 protein when incubated with supernatant taken 
from isolated gp130fl  ox hepatocytes (mean  the SD;   n    5; *, P  0.01 
vs. control;   # ,  P   0.05 vs. gp130  –  ). Fig. S2 is available at http://www.jem
.org/cgi/content/full/jem.20070120/DC1.   
  Figure 4.     Stimulation and migration of macrophages upon SAA 
stimulation. (A) mRNA expression of the CCR2 receptor. CCR2 is up-
regulated as early as 1 h after stimulation with SAA (mean  the SEM; 
  n    5; *, P  0.05 vs. 0 h). (B) The migration of macrophages toward CCL2 
or SAA was signifi  cantly enhanced compared with control (set to 100%) 
The migratory potency of macrophages to CCL2 could be still increased by 
preincubation of macrophages with SAA compared with the control, CCL2 
or SAA alone (mean  the SEM;   n    5; *, P  0.05 vs. control;   # ,  P   
0.05 vs. CCL2). (C) Enhanced migration of macrophages toward CCL2 after 
preincubation with APP containing supernatant of stimulated hepato-
cytes from gp130fl  ox mice compared with supernatant from gp130  –   mice 
(mean  the SEM;   n    9; *, P  0.05 vs. control;   # ,  P   0.05 vs. gp130fl  ox). 
(D) Reduced macrophage migration toward CCL2 after preincubation with 
supernatant of LIF-stimulated hepatocytes from gp130fl  ox mice pre-
treated with a SAA-antibody compared with supernatant pretreated with 
an unspecifi  c IgG antibody (mean  the SEM;   n    4; *, P  0.05 vs. IgG-
pretreated  supernatant).   1940 GP130 SIGNALING IN ATHEROSCLEROSIS | Luchtefeld et al.
This is consistent with a gene eff  ect for a complex, poly-
genic disease. The allele frequencies of the markers are listed 
in   Table III  .   Finally, we performed a haplotype-based asso-
ciation. A haplotype comprised of the four SNPs with posi-
tive single-point association as part of the overall haplotype 
block also showed a signifi  cant association (family-based 
association, P  0.05). 
  To further validate our observation from the family-based 
approach, we investigated six haplotype-tagging SNPs in the 
IL6ST gene in an independent, population-based study sam-
ple from the PopGen coronary heart disease program (www
.popgen.de) comprising 1,090 patients aged 55 yr with 
proven atherosclerosis determined by angiography. A signifi  cant 
association was observed between SNP rs11574780 and the trait 
  “  ostium  ”   (crude OR 1.64, P = 0.048; adjusted OR 1.74, 
same haplotype block showed a trend for association with 
CAD. The phenotypic presentation of CAD is complex, as it 
relates to the location and degree of the disease. Therefore, 
we subsequently analyzed clinical subphenotypes of CAD, 
namely the atherosclerotic disease patterns as determined by 
angiography. To systematically characterize CAD disease 
burden, we previously analyzed the CAD disease pattern in 
families and described the heritable pattern of clinical sub-
phenotypes, as determined by coronary angiography. We 
detected a particularly high heritability for the disease mani-
festation in the proximal part of coronary arteries, including 
lesions at the coronary ostium (  17  ). When analyzing these 
clinical subphenotypes, a signifi  cant association (P  0.005) 
was observed between rs1900173 and an atherosclerotic lesion 
at the ostium of the left or right coronary artery, as defi  ned 
by the Coronary Artery Surgery Study classifi  cation (  18  ). 
Additional SNPs located in the same LD block showed asso-
ciation to this trait at the P  0.05 signifi  cance level.   Table II   
summarizes the results of the subset and full dataset SNP 
analysis.   Permutation testing using the algorithm implemented 
in QTDT determined that the association of rs1900173 with 
the trait   “  ostium  ”   met the required global signifi  cance level, 
with an empirical P value of 0.0004. Even after adjustment 
for multiple testing using the Bonferroni correction, taking 
into account the haplotype structure and the number of dis-
ease segments analyzed (18 disease segments and 3 haplotype 
blocks), the association signal for rs1900173 remained signifi  -
cant (P  0.05). Furthermore, we used generalized estimat-
ing equations taking into account the familial correlation of 
the individuals to estimate the eff  ect of the signifi  cant associ-
ated SNP. The odds ratio (OR) for ostium stenosis for car-
riers of the rare allele of rs1900173 is 1.92 (95% CI, 1.033.6). 
  Figure 5.     Haplotype diagram depicting the linkage disequilibrium 
structure between the SNPs in IL6ST gene. Nine SNPs fall into one 
block with strong linkage disequilibrium spanning 31 kb (block 1).     
    Table II.   Signifi  cant results (P values) of association analysis 
in the IL6ST gene in 513 MI families using QTDT 
SNP CHD CHD Ostium Ostium
Crude 
analysis
Fully adjusted 
model
Crude 
analysis
Fully 
adjusted 
model
rs1063560 NS NS NS NS
rs6861772 NS NS NS NS
rs11741953 NS NS NS NS
rs3729960 0.0882 NS 0.065 NS
rs10940495 0.0185 0.0078 NS NS
rs1373998 NS NS NS NS
rs6894414 NS NS 0.0326 0.07
rs3729961 NS NS 0.0201 0.043
rs7719246 NS NS 0.0862 0.097
rs1900173 0.081 NS 0.0034 0.0023
rs10471960 NS NS NS NS
The fully adjusted model includes age, gender, smoking, diabetes, BMI, CAD/MI, 
TC/HDL ratio, lipid medication, and three CRP gene SNPs previously associated with 
CRP levels.
    Table III.    Allele frequencies of markers 
SNP rs# MAF 
  % 
1063560 1
6861772 12
11741953 11
3729960 11
10940495 29
1373998 12
6894414 10
3729961 10
7719246 12
1900173 7
10471960 11
11574780 4
MAF, minor allele frequency.JEM VOL. 204, August 6, 2007 
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  To confi   ne the APP-dependent APR for macrophage 
migration to the aortic tissue, we determined the expression 
of CCL2 in isolated MASMCs, as well as CCR2 expression 
in mouse macrophages. Furthermore, we examined macro-
phage migration toward CCL2 after SAA stimulation and after 
stimulation with the supernatant of LIF-treated hepatocytes 
from gp130 and gp130fl  ox mice. CCL2 and CCR2 expres-
sion and macrophage migration toward CCL2 are increased 
upon stimulation with SAA or the supernatant from hepato-
cytes from gp130fl  ox mice, but signifi  cantly reduced when 
stimulated with supernatant from gp130 hepatocytes. These 
results suggest that a hepatocyte gp130-dependent APR in 
vivo enhances the local synthesis and release of monocyte/
macrophage recruiting factors, such as CCL2 and their recep-
tor CCR2, which stimulate macrophage migration into the 
vessel wall as one step in the initiation of atherosclerotic plaques. 
Additionally, preincubation of supernatant from LIF-stimulated 
gp130fl  ox hepatocytes with a SAA antibody signifi  cantly 
reduced macrophage migration compared with a pretreated 
IgG control, pointing to SAA as the responsible APP for macro-
phage migration in murine atherosclerosis. 
  We demonstrate that SAA in mouse mediates eff  ects similar 
to these observed for CRP in humans, e.g., induction of CCR2 
in monocytes (  26  ). These results are consistent with the 
observation that CCR2 deletion in apoE/ mice reduces 
atherosclerotic plaque development by decreasing macrophage 
recruitment to the atherosclerotic plaque (  14  ). In addition, the 
fi  ndings from the animal model further imply that gp130-
dependent acute phase reactants such as SAA do not only refl  ect 
diff  erent degrees of infl  ammation, which has been suggested as 
an independent risk factor in a variety of cardiovascular diseases. 
These observations are consistent with the notion that gp130-
dependent acute phase reactants, such as SAA, are direct medi-
ators for plaque formation in murine atherosclerosis. 
  Given the known diff  erences between the mouse model 
and humans related to the infl  ammatory response, as well as 
disease mechanisms, and after the functional results from our 
animal model, the question arises whether gp130 also plays a 
signifi  cant role in human atherosclerosis. Comparative genet-
ics methods off  er a successful strategy for the translation of 
fi  ndings from rodent disease models, i.e., inbred strains, trans-
genic, or knockout models, to clinically relevant settings by 
identifying homologous genes in the human genome for ge-
netic association studies (  27, 28  ). Therefore, we tested in two 
independent populations whether genetic variation in the hu-
man homologue of gp130, i.e., IL6ST, infl  uences phenotypes 
of atherosclerosis. We obtained signifi  cant evidence for an 
  association of SNPs in the human homologue IL6ST gene and 
atherosclerotic disease in humans for CAD as a phenotype in a 
large set of families. Although the direct mechanism of action 
for the identifi  ed SNPs remains to be determined in future ex-
periments, the results from our animal models in conjunction 
with the association data suggests an activating eff  ect. 
  More importantly, we also detected a highly signifi  cant 
association for a stenosis of the ostium of the coronary arteries. 
The association with an atherosclerotic lesion at the ostium is 
P = 0.032, adjusted for age, sex, body mass index (BMI), hyper-
tension, diabetes, TC/HDL ratio, and smoking) when com-
paring patients with and without ostium stenoses (30%), thus 
replicating and further corroborating our initial fi  ndings. 
    DISCUSSION   
  Systemic loss of one IL-6 cytokine member exhibits mild or 
unexpected morphological vascular phenotypes (  19  ), e.g., 
systemic deletion of IL-6 in a mouse model prone to athero-
sclerosis elicits detrimental eff  ects on atherosclerotic plaque 
development, potentially via an IL-6dependent down-
regulation of its counteracting cytokine IL-10 (  20  ). The com-
plete systemic gp130 knockout, in contrast, shows profound 
defects in cardiac and hematopoetic development, resulting in 
premature death in utero or soon after birth. Thus, to delin-
eate the role of the hepatic APR in atherosclerosis, we selec-
tively deleted the gp130 receptor in hepatocytes using the 
Cre-loxP system. The genetic modifi  cation was confi  rmed 
by a PCR reaction demonstrating the gene inactivation ex-
clusively in liver, but not in heart, aorta, or spleen, and by 
functional analysis of gp130-dependent, LIF-induced STAT3 
phosphorylation and SAA release from hepatocytes from con-
trols, but not from gp130 mice. Thus, the introduction of 
loxP sites to the gp130 gene had no impact on the functional-
ity (  12  ) of the gp130 gene; however, Cre-mediated deletion 
in hepatocytes inactivates the gene and abolishes the APR. 
  APPs are induced by dietary cholesterol (  21  ) and serve as 
markers of vascular infl  ammation (  22  ). Furthermore, it could be 
demonstrated that SAA is deposited in murine atherosclerosis 
at all stages of lesion development (  23  ), and the SAA immuno-
reactive area correlates highly with the lesion area, suggesting 
a possible role for SAA-mediated lipoprotein retention in 
atherosclerosis. Additionally, SAA serves as a potent chemoat-
tractant for mouse macrophages and neutrophils (  24  ), suggesting 
that SAA exerts infl  ammatory potencies beyond its traditional 
role as a marker of infl  ammation. Therefore, we investigated 
whether a high-cholesterol Western diet induces gp130-
dependent SAA expression and, subsequently, atherosclerotic 
plaque formation. We observed signifi  cantly reduced SAA 
level in gp130 mice compared with gp130fl  ox mice, which 
is accompanied by a reduced atherosclerotic lesion area. 
Collectively, these fi  ndings clearly demonstrate that the APR 
amplifi  es the development of aortic atherosclerotic lesions. 
  In early atherosclerotic lesions, macrophages are recruited 
into the vessel, take up cholesterol deposits, develop into 
foam cells, and form the typical lipid core (  25  ) of the lesion. 
We examined the role of APR in macrophage recruitment to 
the vessel wall in vivo and observed a signifi  cant reduction of 
the macrophage-positive plaque area in gp130 mice. These 
fi  ndings further emphasize the impact of hepatic gp130 in 
particular, as it relates to the cellular components of the ath-
erosclerotic disease process. Whether or not this process in-
volves additional mechanisms enhanced by gp130-dependent 
acute phase reactants, such as the complement cascade, scav-
enger receptors, or NF-
Binducing oxygen free radicals, 
will be further evaluated. 1942 GP130 SIGNALING IN ATHEROSCLEROSIS | Luchtefeld et al.
  Migration experiment 
  10  5   serum-starved murine macrophages (MHS cells) were used per well 
(Corning Transwell) to measure migration over a period of 24 h through an 
8-m pore size membrane in response to 50 ng/ml murine CCL2 (Bio-
source), 25 g/ml SAA with previous stimulation with or without 25 g/ml 
SAA, supernatant from LIF-stimulated hepatocytes for 1 h, or supernatant 
from LIF-stimulated hepatocytes pretreated either with a goat anti  –  mouse 
SAA antibody (10 g/10 l for 1 h; R&D Systems) or with an unspecifi  c 
goat anti–mouse IgG (10 g/10 μl for 1 h; Sigma-Aldrich). 
  Protein cytokine array 
  A protein cytokine array kit was purchased from RayBiotech. In brief, the 
membranes were blocked with a blocking buff  er, and then 1 ml of me-
dium from either unstimulated or SAA-stimulated (25 g/ml for 3 h) 
SMC was added and incubated at room temperature for 2 h. The mem-
branes were washed, and 1 ml of primary biotin-conjugated antibody was 
added and incubated at room temperature for 2 h. The membranes were 
incubated with 2 ml of horseradish peroxidase  –  conjugated streptavidin at 
room temperature for 30 min. The membranes were developed by using 
enhanced chemiluminescence-type solution, exposed to fi  lm, and processed 
by autoradiography. 
  Western blot 
  30-g protein extracts were separated by denaturing 10% SDS-PAGE and 
transferred to PVDF membrane (GE Healthcare). Proteins were probed with 
a rabbit anti  –  mouse p-STAT-3 antibody (Cell Signaling Technology) and 
visualized by secondary anti  –  rabbit-HRP antibody (GE Healthcare) and 
ECL solution. Equal protein loading was verifi  ed by reprobing the mem-
brane with rabbit anti  –  mouse STAT-3 (Santa Cruz Biotechnology). STAT3 
phosphorylation was quantifi  ed relative to total STAT3 expression using 
GelDoc image analysis system (Bio-Rad Laboratories). 
  Tissue preparation 
  For the analysis of atherosclerotic lesion areas, aortas were prepared en 
face, as previously described (  20  ). Within the aortic root, lesion areas were 
analyzed in cross sections obtained at the level of all three leafl  ets of the 
aortic valve. To assess cellular morphology, cross sections were stained with 
hematoxylin and eosin. The lesion areas in the aortic root were   determined 
via computer-assisted image quantifi  cation (Axio Vision; Carl Zeiss Micro-
Imaging, Inc.) (  32  ). For immunohistochemistry, the aorta was isolated, 
embedded in OCT, divided into four sections, and cut systematically every 
60 m in 6-m cross sections with plaques to obtain serial sections 
throughout the vessel (  20  ). Monocytes/macrophages were detected with 
rat anti  –  mouse MOMA-2 antibody (Acris), followed by rabbit mouse-
absorbed anti  –  rat antibody-HRP (Vector Laboratories) using AEC+ sub-
strate chromogen (DakoCytomation). Morphometric data were obtained 
by image analysis (QWin software; Leica; Axiovert 200M; Carl Zeiss Micro-
Imaging, Inc.). 
  Plasma analyses 
  Plasma samples were collected after an overnight fast. TC and triglycerides 
were determined by colorimetric assays (WAKO Chemicals) after the sepa-
ration of lipoprotein subfractions by ultracentrifugation (  20, 33  ). CCL2 (R  &  R 
System) and SAA (Tridelta) were measured by ELISA. 
  Semiquantitative RT-PCR 
  Gene expression was assessed by semiquantitative RT-PCR. Total RNA 
was isolated using TriFast-Reagent (peqLAB), and reverse transcribed 
(Superscript reverse transcriptase; Invitrogen) with oligo(dT) primers. The 
RT products were amplifi  ed using   Taq   DNA polymerase (Invitrogen, Bio-
metra cycler). PCR was performed for 18 cycles (18S rRNA), for 34 cycles 
(CCL2), and for 40 cycles (CCR2), using oligonucleotides obtained from 
MWG Biotech. PCR products were separated on 1% Agarose gels and 
quantifi  ed relative to 18S rRNA expression using the GelDoc image analysis 
system (Bio-Rad Laboratories). 
of particular clinical relevance because occlusion of the ostium 
or proximal segment of a coronary artery (i.e., the left anterior 
descending artery) results in a substantial reduction of blood 
fl  ow to large parts of the left ventricle. 
  Consequently, occlusion of the ostium or the left anterior 
descending artery is often considered the morphological cor-
relate of sudden cardiac death or MI with a particularly high 
mortality. To further evaluate the robustness of this strong 
association signal in families, we could replicate the associa-
tion signal for an ostium stenosis in a second independent 
population-based cohort. In light of the functional evidence 
from the animal model, the replicated association in humans 
that remained signifi  cant after adjusting for multiple testing, 
together with a haplotype-based analysis, provides strong 
evidence that gp130 also plays an important role in human 
disease. Our fi  ndings might therefore guide toward an improved 
risk assessment in patients with mutations in the gp130 gene 
and an increased risk of CAD. 
  In summary, we demonstrated that a gp130-driven acute 
phase reaction is a critical regulator for the process of athero-
sclerotic plaque development. Our observations strengthen 
the utility of comparative genetics approaches for the identi-
fi  cation of susceptibility genes for common, complex diseases 
in humans, and thus allow a direct translation of experimental 
results into clinical relevance. 
    MATERIALS AND METHODS   
  Mice 
  Mice with a fl  oxed gp130 gene (  gp130    fl  ox/fl  ox    ) and mice with the albumin-
specifi  c transgene for Cre-recombinase (  alb-cre  tg    ) were crossed with apolipo-
protein E  –  defi  cient mice (apoE/; Charles River Laboratories) to obtain mice 
lacking gp130 specifi  cally within hepatocyte (alb-cre  tg  ;gp130    fl  ox/fl  ox  ;apoE/). 
Littermates with fl  oxed gp130 (gp130    fl  ox/fl  ox  ;apoE/) and the wild-type allele 
(gp130  +/+  ;apoE/) served as controls. All animals were backcrossed for 10 
generations on a C57BL/6 genetic background, kept under specifi  c pathogen-
free conditions in the animal facility at the Medizinische Hochschule 
Hannover (Hannover, Germany). All experiments were approved by the 
governmental animal ethics committee and performed according to the 
guidelines of the Federation of European Animal Science Associations. At 
10 wk of age, male mice were subjected to Western-type dieting (20% fat, 
0.1% cholesterol, and Altromin) for 8 and 12 wk. 
  Genotyping 
  All mice were genotyped by PCR using previously described primer se-
quences (  29  ), and deletion at the exon 16 locus of the gp130 gene was veri-
fi  ed as recently reported (  13  ). 
  Cell culture 
  Hepatocytes were isolated (  30  ), 10  6   cells were cultured on 6-cm culture 
plates (Nunc) with DME (Invitrogen) containing 4.5 g/L glucose, 10% FCS, 
and penicillin/streptomycin for 24 h. Cells were stimulated with 50 ng/ml 
LIF (Chemicon) for 0–6 h. MASMCs were isolated as described previously 
(  31  ) and maintained in DME (1.5 g/liter glucose; Biochrom). Under serum-
free conditions, cells were stimulated either with 12.5, 25, or 50 g/ml SAA 
(Peprotech) or with supernatant of hepatocytes diluted 1:2 in DME for the 
indicated times. Macrophages (MH-S murine alveolar macrophage cell line; 
LGC Promochem) were cultivated in nonadherent suspension culture with 
RPMI 1640 (Invitrogen) containing 10% FCS, penicillin/streptomycin, and 
3.5 l/liter -mercaptoethanol. Cells were stimulated under serum depriva-
tion (1% FCS) for the indicated times. JEM VOL. 204, August 6, 2007 
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the PopGen study sample was performed using logistic regression analysis 
as implemented in SPSS 12.0. P values were adjusted for age, gender, BMI, 
presence or absence of diabetes, smoking status, and TC/HDL ratio. Before 
the analysis, all SNPs were evaluated for deviation from Hardy-Weinberg-
Equilibrium by 2 statistics. 
  Online supplemental material 
  Fig. S1 shows mouse cytokines that are up-regulated and released from MASMC 
stimulated with SAA. Fig. S2 shows that the SAA-induced CCR2 release from 
MASMC is not mediated by LPS. The online version of this article is available 
at http://www.jem.org/cgi/content/full/jem.20070120/DC1. 
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  Statistical analysis 
  Data are presented as the means  the SD or the SEM, as indicated. Com-
parisons between groups were performed by Student  ’  s   t   test assuming two-
tailed distribution and unequal variances. 
  Study population 
  All study participants gave written informed consent, and the study was 
approved by the ethics committees at the Medical College of Wisconsin 
(Milwaukee, WI), the University of Regensburg (Regensburg, Germany), 
and the University of Kiel (Kiel, Germany). 
  Subject ascertainment and phenotyping 
  MI/CAD.     An indepth description of the patient ascertainment strategy and 
the clinical characteristics of the study population have been previously re-
ported for MI families (  15  ). In brief, Western European families were in-
cluded in the study if probands had suff  ered a MI (as documented by criteria 
chosen according to the published defi  nitions of the Monitoring of Trends 
and Determinants in Cardiovascular Disease investigators of the World 
Health Organization) before the age of 60 and aff  ected siblings had a MI or 
underwent percutaneous transluminal coronary angioplasty or coronary ar-
tery bypass grafting. Subphenotypes of CAD were collected from coronary 
angiographies. A detailed description of the phenotypes, the phenotyping 
protocol, and a heritability analysis has been previously published (  17  ). In 
brief, coronary arteries were divided into 16 subsegments. Qualitative pheno-
types were used for family-based association analysis. 
  The PopGen (www.popgen.de) coronary heart disease program scruti-
nized the records from all patients in Northern Schleswig-Holstein who un-
derwent cardiac catheterization between January 1, 1997 and June 30, 2003. 
Because of the geographic characteristics of the region, this represents the 
entire disease population, which is diagnosed at only six coronary care centers. 
1,607 patients 55 yr old with diagnosis of atherosclerosis through cardiac 
catheter were contacted, and 1,090 patient DNA samples (M 921  –  83.6%) 
with corresponding clinical datasets were available for the study. Catheter 
reports were evaluated and catheter fi  lms rescored if necessary. A full set of 
clinical and laboratory data was extracted from patient fi  les. 
  SNP identifi  cation and genotyping 
  Based on the available SNP and linkage disequilibrium data from public 
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3    -regions. Only SNPs with a minor allele frequency 
5% for the IL6ST 
gene and fl   anking SNP were selected. Genotyping of SNPs rs1063560, 
rs6861772, rs11741953, rs3729960, rs10940495, rs1373998, rs6894414, 
rs3729961, rs7719246, rs1900173, and rs10471960 was performed at the 
Medical College of Wisconsin using TaqMan technology (Applied Biosys-
tems). For genotyping the PopGen samples, 6 SNPs (rs7719246, rs11574780, 
rs10940495, rs6870870, rs10471960, and rs1900173) were genotyped at the 
University of Kiel using SNPlex technology (Applied Biosystems). 
  Statistical analysis 
  Linkage disequilibrium estimation.     The analysis program Haploview 
(version 3.2) was used to calculate and visualize linkage disequilibrium and 
haplotype-block patterns of the genotyped SNPs (  34  ). 
  Association analysis.     The QTDT program was used for the quantitative 
family-based single SNP association analysis and permutation testing (  35  ). 
P values for single SNP association analysis were adjusted for age, gender, 
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of CAD/MI, lipid medication, and TC/HDL ratio. Empirical P values were 
calculated using a permutation procedure with 10,000 permutations, as im-
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